MainStay WMC Value R3 (MMAPX)
29.53
+0.49 (+1.69%)
USD |
May 27 2022
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 1.37% | 1.040B | 0.66% | 23.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| -50.04M | 5.91% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks long-term appreciation of capital. The fund invests in equity securities issued by companies of any size or market capitalization range. While it does not limit its investments to issuers within a particular capitalization range, it generally invests in large capitalization companies. The fund may invest in securities of foreign issuers, including securities of emerging market country issuers. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | MUBFX |
| Equity Style | Large Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Value |
| Category Index | Russell 1000 Value TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | New York Life Investment Management LLC |
| Prospectus Benchmark Index | |
| Russell 1000 Value TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Adam Illfelder | 1.01 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
62
-50.04M
-4.342B
Category Low
19.90B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of April 30, 2022
Performance Versus Category
As of May 27, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of May 27, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| UnitedHealth Group Inc | 3.64% | 507.11 | 0.97% |
| JPMorgan Chase & Co | 3.07% | 131.27 | 1.41% |
| Pfizer Inc | 2.99% | 53.91 | -0.15% |
| Cisco Systems Inc | 2.65% | 45.62 | 1.40% |
| Anthem Inc | 2.36% | 520.55 | 1.58% |
| Comcast Corp Class A | 2.33% | 44.16 | 0.07% |
| Alphabet Inc Class C | 2.22% | 2255.98 | 4.16% |
| ConocoPhillips | 2.18% | 114.60 | 1.28% |
| Eli Lilly and Co | 2.17% | 323.48 | 3.20% |
| MetLife Inc | 2.13% | 67.72 | 1.21% |
Basic Info
| Investment Strategy | |
| The investment seeks long-term appreciation of capital. The fund invests in equity securities issued by companies of any size or market capitalization range. While it does not limit its investments to issuers within a particular capitalization range, it generally invests in large capitalization companies. The fund may invest in securities of foreign issuers, including securities of emerging market country issuers. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | MUBFX |
| Equity Style | Large Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Value |
| Category Index | Russell 1000 Value TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | New York Life Investment Management LLC |
| Prospectus Benchmark Index | |
| Russell 1000 Value TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Adam Illfelder | 1.01 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (5-27-22) | 0.66% |
| 30-Day SEC Yield (6-30-09) | Upgrade |
| 7-Day SEC Yield (7-17-09) | Upgrade |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 0.0527 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of March 31, 2022
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 4/28/2006 |
| Last Annual Report Date | 10/31/2021 |
| Last Prospectus Date | 2/28/2022 |
| Share Classes | |
| MAPAX | A |
| MAPBX | B |
| MAPRX | Retirement |
| MMPCX | C |
| MMPDX | Retirement |
| MPRRX | Retirement |
| MSMIX | Inv |
| MUBFX | Inst |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |